Beneficial effect of a sturgeon-based bioactive compound on gene expression of tumor necrosis factor-α, matrix metalloproteinases and type-10 collagen in human chondrocytes

Journal of Biological Regulators and Homeostatic Agents

Volumn 26, Issue 3, 2012, Pages 337-345

  Catanzaro, R ^a   Marotta, Francesco ^b   Jain, S ^c   Rastmanesh, R ^d   Allegri, F ^e   Celep, G ^f   Lorenzetti, A ^b   Polimeni, A ^b   Yadav, H ^c  

^a UNIVERSITY OF CATANIA   (Italy)

^b ReGenera Research Group for Aging Intervention   (Italy)

^c NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^d SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e FBF Hospital   (Italy)

^f GAZI UNIVERSITY   (Turkey)

Author keywords

Chondhrocyte; IL stimulation; LD 1227; Marine biology compound; Osteoarthritis

Indexed keywords

ANTIINFLAMMATORY AGENT; COLLAGEN; COLLAGEN TYPE 10; COLLAGENASE 3; DNA; ELASTIN; GELATIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERSTITIAL COLLAGENASE; LD 1227; RECOMBINANT INTERLEUKIN 1BETA; SYNAPTOTAGMIN I; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BINDING AFFINITY; CARTILAGE; CARTILAGE CELL; CLINICAL ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; DNA BINDING; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME REPRESSION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; KNEE OSTEOARTHRITIS; MALE; NUCLEOTIDE SEQUENCE; PROTEIN DETERMINATION; PROTEIN SYNTHESIS; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; STURGEON; WESTERN BLOTTING; ZYMOGRAPHY;

AGED; ANIMALS; CELLS, CULTURED; CHONDROCYTES; COLLAGEN TYPE X; COMPLEX MIXTURES; FEMALE; FISH PROTEINS; FISHES; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-1BETA; MALE; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 13; MIDDLE AGED; NF-KAPPA B; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84868156571     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Zhang Y, Jordan JM. Epidemiology of osteoarthritis. Clin Geriatr Med 2010; 26:355-69.
2. Arden N, Nevitt MC. Osteoarthritis: epidemiology. Best Pract Res Clin Rheumatol 2006; 20:3-25. (Pubitemid 43230460)
3. Hjelle K, Solheim E, Strand T, Muri R, Brittberg M. Articular carti-lage defects in 1,000 knee arthroscopies. Arthroscopy 2002; 18:730-34. (Pubitemid 36114627)
4. Kemp JL, Collins NJ, Makdissi M, Schache AG, Machotka Z, Crossley K. Hip arthroscopy for intra-articular pathology: a systematic review of outcomes with and without femoral osteoplasty. Br J Sports Med 2011; [Epub ahead of print]
5. Filaretova LP, Bagaeva TR, Morozova OY, Zelena D. The healing of NSAID-induced gastric lesion may be followed by small intestinal and cardiovascular side effects. J Physiol Pharmacol 2011; 62:619-25.
6. Wang QC, Shi YY, Shen PZ, Xu Y. Effect of aging and sports-loading on articular cartilage of C57 black mice - a histopathological study[J]. Zhongguo Gu Shang 2000; 13:517-18. Chinese with abstract in English.
7. Flugge LA, Miller-Deist LA, Petillo PA. Towards a molecular understanding of arthritis. Chem Biol 1999; 6:R157-R166. (Pubitemid 29363164)
8. Takaishi H, Kimura T, Dalal S, Okada Y, D' Armiento J. Joint diseases and matrix metalloproteinases: a role for MMP-13. Curr Pharm Biotechnol 2008; 9:47-54. (Pubitemid 351266969)
9. Goldring MB, Otero M, Tsuchimochi K, Ijiri K, Li Y. Defining the roles of inflammatory and anabolic cytokines in cartilage metabolism. Ann Rheum Dis 2008; 67(S):iii75-iii82.
10. Little CB, Flannery CR, Hughes CE, Goodship A, Caterson B. Cytokine induced metalloproteinase expression and activity does not correlate with focal susceptibility of articular cartilage to degeneration. Osteoarthritis Cartilage 2005; 13:162-70. (Pubitemid 40220807)
11. Watanabe Y, Namba A, Honda K, Aida Y, Matsumura H, Shimizu O, Suzuki N, Tanabe N, Maeno M. IL-1β stimulates the expression of prostaglandin receptor EP4 in human chondrocytes by increasing production of prostaglandin E2. Connect Tissue Res 2009; 50:186-93.
12. Kobayashi M, Squires GR, Mousa A, Tanzer M, Zukor DJ, Antoniou J, Feige U, Poole AR. Role of interleukin-1 and tumor necrosis factor alpha in matrix degradation of human osteoarthritic cartilage. Arthritis Rheum 2005; 52:128-35. (Pubitemid 40129241)
13. Goldring SR, Goldring MB. The role of cytokines in cartilage matrix degeneration in osteoarthritis. Clin Orthop Relat Res 2004; 427:S27-36. (Pubitemid 39362798)
14. Pelletier JP, Caron JP, Evans C, Robbins PD, Georgescu HI, Jovanovic D. In vivo suppression of early experimental osteoarthritis by interleukin-1 receptor antagonist using gene therapy. Arthritis Rheum 1997; 40:1012-19. (Pubitemid 27242287)
15. Martinon F, Major A, Tschopp J. The inflammasomes: guardians of the body. Ann Rev Immunol 2008; 27:229-65.
16. Anderson P. Post-transcriptional regulation of tumour necrosis factor alpha production. Ann Rheum Dis 2000; 59:i3-i5.
17. Zainal Z, Longman AJ, Hurst S, Duggan K, Caterson B, Hughes CE, Harwood JL. Relative efficacies of omega-3 polyunsaturated fatty acids in reducing expression of key proteins in a model system for studying osteoarthritis. Osteoarthritis Cartilage 2009; 17:896-905.
18. Altman R, Alarcón G, Appelrouth D, Bloch D, Borenstein D, Brandt K. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. Arthritis Rheum 1991; 34:505-14.
19. van der Sluijs JA, Geesink RG, van der Linden AJ, Bulstra SK, Kuyer R, Drukker J. The reliability of the Mankin score for osteoarthritis. J Orthop Res 1992; 10:58-61.
20. Joos H, Albrecht W, Laufer S, Reichet H, Brenner RE. IL-1 beta regulates FHL2 and other cytoskeleton-related genes in human chondrocytes. Mol Med 2008; 14:150-59. (Pubitemid 351481845)
21. L'Hermette MF, Tourny-Chollet C, Polle G, Dujardin FH. Articular cartilage, degenerative process and repair: current progress. Int J Sports Med 2006; 27:738-44. (Pubitemid 44369572)
22. Kwan Tat S, Amiable N, Pelletier JP, Boileau C, Lajeunesse D, Duval N. Modulation of OPG, RANK and RANKL by human chondrocytes and their implication during osteoarthritis. Rheumatology (Oxford) 2009; 48:1482-90.
23. Komuro H, Olee T, Kühn K, Quach J, Brinson DC, Shikhman A. The osteoprotegerin/receptor activator of nuclear factor kappaB/receptor activator of nuclear factor kappaB ligand system in cartilage. Arthritis Rheum 2001; 44:2768-76. (Pubitemid 34016196)
24. Clérigues V, Guillén MI, Castejón MA, Gomar F, Mirabet V, Alcaraz MJ. Heme oxygenase-1 mediates protective effects on inflammatory, catabolic and senescence responses induced by interleukin-1β in osteoarthritic osteoblasts. Biochem Pharmacol 2012; 83:395-405.
25. Kimura H, Yukitake H, Suzuki H, Tajima Y, Gomaibashi K, Morimoto S. The chondroprotective agent ITZ-1 inhibits interleukin-1 beta-induced matrix metalloproteinase-13 production and suppresses nitric oxide-induced chondrocyte death. J Pharmacol Sci 2009; 110:201-11.
26. Mcintyre KW, Shuster DJ, Gillooly KM, et al. A highly selective inhibitor of I kappa B kinase, BMS-345541, blocks both joint inflammation and destruction in collagen-induced arthritis in mice. Arthritis Rheum 2003; 48:2652-59. (Pubitemid 37129443)
27. Marotta F, Polimeni A, Solimene U, Lorenzetti A, Minelli E, Jain S, Rastmanesh R, Sedriep S, Soresi V. Beneficial modulation from a high-purity caviar-derived homogenate on chronological skin aging. Rejuvenation Res 2012; 15:174-77.
28. Marotta F, Chui DH, Yadav H, et al. Effective properties of a sturgeon-based bioactive compound on stress-induced hippocampal degeneration and on in vitro neurogenesis. J Biol Regul Homeost Agents (in press).